Strategic Partnerships Active collaborations with Cleveland Clinic Wellness and Broad Clinical Labs demonstrate a strong channel for co-developed diagnostics and translational research. Sales opportunities include expanding adoption of Xenium and Atera within academic medical centers and CRO networks through integrated hardware, reagents, and software with bundled services.

AI Collaboration The company’s AI driven collaboration with Biomy to develop Virtual Cell foundation models signals demand for AI ready data platforms and cloud workflows. Opportunities to monetize data access, hosted analysis, and AI model development support, leveraging Azure infrastructure to accelerate discovery and diagnostics.

Platform Growth Launch of the Atera spatial platform alongside Xenium positions 10x Genomics to cross-sell to labs seeking end-to-end spatial biology workflows. Target opportunities include bundling hardware, reagents, software licenses, and professional services to academic, pharma, and contract research organizations.

Global Expansion Global partnerships and media coverage indicate readiness for multinational deployments. Sales focus can be on pharma and CROs with regional service, training, and localized software to scale adoption in Europe, Asia-Pacific, and other regions.

Services Customization Opportunity exists to expand value-added services such as custom panels, data analysis, pipeline integration, and consulting. By offering end-to-end workflows and training, 10x Genomics can reduce time-to-insight and strengthen customer retention.